同步放化疗时机对新诊断胶质母细胞瘤的影响：当前证据的批判性综述
Impact of Timing of Concurrent Chemoradiation for Newly Diagnosed Glioblastoma: A Critical Review of Current Evidence.
作者信息
Han Seunggu J, Englot Dario J, Birk Harjus, Molinaro Annette M, Chang Susan M, Clarke Jennifer L, Prados Michael D, Taylor Jennie W, Berger Mitchel S, Butowski Nicholas A
机构信息
*Department of Neurological Surgery, ‡Department of Epidemiology and Biostatistics, and §Department of Neurology, University of California, San Francisco, San Francisco, California.
出版信息
Neurosurgery. 2015 Aug;62 Suppl 1(Suppl 1):160-5. doi: 10.1227/NEU.0000000000000801.
Abstract
EORTC/NCIC, European Organisation for Research and Treatment of Cancer/National Cancer Institute of CanadaGBM, glioblastomaOS, overall survivalPFS, progression-free survivalSEER, Surveillance, Epidemiology, and End ResultsTMZ, temozolomide.
摘要
欧洲癌症研究与治疗组织/加拿大国家癌症研究所（EORTC/NCIC）；胶质母细胞瘤（GBM）；总生存期（OS）；无进展生存期（PFS）；监测、流行病学与最终结果（SEER）；替莫唑胺（TMZ）
相似文献
1
Impact of Timing of Concurrent Chemoradiation for Newly Diagnosed Glioblastoma: A Critical Review of Current Evidence.
Neurosurgery. 2015 Aug;62 Suppl 1(Suppl 1):160-5. doi: 10.1227/NEU.0000000000000801.
2
Feasibility of the EORTC/NCIC Trial Protocol in a Neurosurgical Outpatient Unit: The Case for Neurosurgical Neuro-Oncology.
J Neurol Surg A Cent Eur Neurosurg. 2015 Jul;76(4):298-302. doi: 10.1055/s-0034-1396437. Epub 2015 Apr 27.
3
The Effect of Timing of Concurrent Chemoradiation in Patients With Newly Diagnosed Glioblastoma.
Neurosurgery. 2015 Aug;77(2):248-53; discussion 253. doi: 10.1227/NEU.0000000000000766.
4
Temozolomide during radiotherapy of glioblastoma multiforme : Daily administration improves survival.
Strahlenther Onkol. 2017 Nov;193(11):890-896. doi: 10.1007/s00066-017-1110-4. Epub 2017 Feb 14.
5
Treatment of newly diagnosed malignant glioma in the elderly people: new trials that impact therapy.
Int J Clin Pract. 2013 Dec;67(12):1225-7. doi: 10.1111/ijcp.12258.
6
Phase 1 dose escalation trial of the safety and pharmacokinetics of cabozantinib concurrent with temozolomide and radiotherapy or temozolomide after radiotherapy in newly diagnosed patients with high-grade gliomas.
Cancer. 2016 Feb 15;122(4):582-7. doi: 10.1002/cncr.29798. Epub 2015 Nov 20.
7
Validation of the Effectiveness and Safety of Temozolomide during and after Radiotherapy for Newly Diagnosed Glioblastomas: 10-year Experience of a Single Institution.
J Korean Med Sci. 2015 Nov;30(11):1597-603. doi: 10.3346/jkms.2015.30.11.1597. Epub 2015 Oct 16.
8
Concurrent Chemoradiotherapy with Temozolomide Followed by Adjuvant Temozolomide for Newly Diagnosed Glioblastoma Patients: A Retrospective Multicenter Observation Study in Korea.
Cancer Res Treat. 2017 Jan;49(1):193-203. doi: 10.4143/crt.2015.473. Epub 2016 Jun 27.
9
Treatment options for glioblastoma.
Neurosurg Focus. 2006 Apr 15;20(4):E19. doi: 10.3171/foc.2006.20.4.12.
10
Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial.
JAMA. 2015 Dec 15;314(23):2535-43. doi: 10.1001/jama.2015.16669.
引用本文的文献
1
Unlocking the Potential of Ultra-High Dose Fractionated Radiation for Effective Treatment of Glioblastoma in Mice.
J Cancer. 2024 May 30;15(13):4060-4071. doi: 10.7150/jca.95148. eCollection 2024.
2
Unlocking the potential of ultra-high dose fractionated radiation for effective treatment of glioblastoma.
Res Sq. 2023 Nov 1:rs.3.rs-3500563. doi: 10.21203/rs.3.rs-3500563/v1.
3
Advances in Preclinical/Clinical Glioblastoma Treatment: Can Nanoparticles Be of Help?
Cancers (Basel). 2022 Oct 10;14(19):4960. doi: 10.3390/cancers14194960.
4
Intranasal Administration of Catechol-Based Pt(IV) Coordination Polymer Nanoparticles for Glioblastoma Therapy.
Nanomaterials (Basel). 2022 Apr 5;12(7):1221. doi: 10.3390/nano12071221.
5
Antitumor Effects of 5-Aminolevulinic Acid on Human Malignant Glioblastoma Cells.
Int J Mol Sci. 2021 May 25;22(11):5596. doi: 10.3390/ijms22115596.
6
The Glioblastoma Microenvironment: Morphology, Metabolism, and Molecular Signature of Glial Dynamics to Discover Metabolic Rewiring Sequence.
Int J Mol Sci. 2021 Mar 24;22(7):3301. doi: 10.3390/ijms22073301.
7
Pre-Radiotherapy Progression after Surgery of Newly Diagnosed Glioblastoma: Corroboration of New Prognostic Variable.
Diagnostics (Basel). 2020 Sep 5;10(9):676. doi: 10.3390/diagnostics10090676.
8
Temporal and spatial modulation of the tumor and systemic immune response in the murine Gl261 glioma model.
PLoS One. 2020 Apr 2;15(4):e0226444. doi: 10.1371/journal.pone.0226444. eCollection 2020.
9
Nasal Drug Delivery of Anticancer Drugs for the Treatment of Glioblastoma: Preclinical and Clinical Trials.
Molecules. 2019 Nov 26;24(23):4312. doi: 10.3390/molecules24234312.
10
The Impact of Timing of Concurrent Chemoradiation in Patients With High-Grade Glioma in the Era of the Stupp Protocol.
Front Oncol. 2019 Mar 27;9:186. doi: 10.3389/fonc.2019.00186. eCollection 2019.
本文引用的文献
1
A single-institution phase II trial of radiation, temozolomide, erlotinib, and bevacizumab for initial treatment of glioblastoma.
Neuro Oncol. 2014 Jul;16(7):984-90. doi: 10.1093/neuonc/nou029.
2
Prognostic value of the interval from surgery to initiation of radiation therapy in correlation with some histo-clinical parameters in patients with malignant supratentorial gliomas.
Contemp Oncol (Pozn). 2012;16(1):34-7. doi: 10.5114/wo.2012.27334. Epub 2012 Feb 29.
3
Waiting times before initiation of radiotherapy might not affect outcomes for patients with glioblastoma: a French retrospective analysis of patients treated in the era of concomitant temozolomide and radiotherapy.
J Neurooncol. 2012 Aug;109(1):167-75. doi: 10.1007/s11060-012-0883-7. Epub 2012 Jun 2.
4
Malignant glioma grade 3 and 4: how relevant is timing of radiotherapy?
Clin Neurol Neurosurg. 2012 Jul;114(6):617-21. doi: 10.1016/j.clineuro.2011.12.024. Epub 2012 Jan 11.
5
Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma.
Neuro Oncol. 2011 Dec;13(12):1331-8. doi: 10.1093/neuonc/nor130. Epub 2011 Sep 6.
6
partDSA: deletion/substitution/addition algorithm for partitioning the covariate space in prediction.
Bioinformatics. 2010 May 15;26(10):1357-63. doi: 10.1093/bioinformatics/btq142. Epub 2010 Apr 7.
7
Enzastaurin plus temozolomide with radiation therapy in glioblastoma multiforme: a phase I study.
Neuro Oncol. 2010 Jun;12(6):608-13. doi: 10.1093/neuonc/nop070. Epub 2010 Feb 15.
8
The timing of cranial radiation in elderly patients with newly diagnosed glioblastoma multiforme.
Neuro Oncol. 2010 Feb;12(2):190-8. doi: 10.1093/neuonc/nop004. Epub 2009 Oct 15.
9
A mathematical model of brain tumour response to radiotherapy and chemotherapy considering radiobiological aspects.
J Theor Biol. 2010 Feb 7;262(3):553-65. doi: 10.1016/j.jtbi.2009.10.021. Epub 2009 Oct 17.
10
Short delay in initiation of radiotherapy may not affect outcome of patients with glioblastoma: a secondary analysis from the radiation therapy oncology group database.
J Clin Oncol. 2009 Feb 10;27(5):733-9. doi: 10.1200/JCO.2008.18.9035. Epub 2008 Dec 29.
Zotero 插件